Patents Assigned to Microsens Medtech Limited
  • Patent number: 8603771
    Abstract: Micro-organisms, including fungi, viruses and bacteria such as Mycobacteria and/or fragments of micro-organisms such as cell wall components present in an aqueous liquid are captured to a solid surface by adding to the liquid a sufficient quantity of a water soluble polymer in the presence of the solid surface to displace the micro-organisms and/or fragments from the liquid to the solid surface. The surface may be provided by a bead. The water soluble polymer may be polyethyleneglycol or polyvinylpyrrolidone.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: December 10, 2013
    Assignee: Microsens Medtech Limited
    Inventors: Christopher John Stanley, Stuart Mark Wilson
  • Publication number: 20130171689
    Abstract: Micro-organisms, including fungi, viruses and bacteria such as Mycobacteria and/or fragments of micro-organisms such as cell wall components present in an aqueous liquid are captured to a solid surface by adding to the liquid a sufficient quantity of a water soluble polymer in the presence of the solid surface to displace the micro-organisms and/or fragments from the liquid to the solid surface. The surface may be provided by a bead. The water soluble polymer may be polyethyleneglycol or polyvinylpyrrolidone.
    Type: Application
    Filed: June 29, 2011
    Publication date: July 4, 2013
    Applicant: MICROSENS MEDTECH LIMITED
    Inventors: Christopher John Stanley, Stuart Mark Wilson
  • Publication number: 20100291564
    Abstract: NAD-dependent ligase is identified as an indicator of micro-organisms in a sample. A method of detecting the presence of an NAD-dependent ligase expressing micro-organism in a sample comprises the steps of: (a) contacting the sample with a nucleic acid molecule which acts as a substrate for NAD-dependent ligase activity in the sample, (b) incubating the thus contacted sample under conditions suitable for NAD-dependent ligase activity; and (c) specifically determining the presence of a ligated nucleic acid molecule resulting from the action of the NAD-dependent ligase on the substrate nucleic acid molecule to indicate the presence of the NAD-dependent ligase expressing micro-organism. The method has a number of applications and kits for carrying out the methods are also provided.
    Type: Application
    Filed: July 9, 2008
    Publication date: November 18, 2010
    Applicant: MICROSEN MEDTECH LIMITED
    Inventors: Christopher John Stanley, Stuart Wilson
  • Publication number: 20100143883
    Abstract: A method for the capture from a sample of micro-organisms having a hydrophobic surface, which method includes contacting the micro-organisms with a capture reagent, which capture reagent has both a hydrophobic character whereby the capture reagent binds the micro-organisms by hydrophobic interaction therewith and a polar character, the capture reagent either being present on a surface and capturing the micro-organisms thereto, or being present in solution, the method then further including capturing the micro-organisms to a surface by binding the capture reagent to the surface by polar interaction between the surface and the capture reagent.
    Type: Application
    Filed: November 23, 2007
    Publication date: June 10, 2010
    Applicant: Microsens Medtech Limited
    Inventors: Stuart Mark Wilson, Christopher John Stanley
  • Patent number: D620606
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: July 27, 2010
    Assignee: Microsens Medtech Limited
    Inventors: Stuart Mark Wilson, Roger John Rosedale